Some people—alarmist, pessimistic, and potentially manipulative—seem to think BVF’s exit is the end of the world. Funds trade in and out all the time – doesn’t change Xanamem’s science or trial potential. And let’s be honest: implying it’s Gourlay’s fault only shows ignorance about how markets actually work. Let them have their 2-cent panic party; the real story is in the data and partnerships ahead.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $60.36M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 1.9¢ | $84.11K | 4.092M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 2057337 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 739569 | 5 |
View Market Depth
| Last trade - 12.57pm 16/06/2025 (20 minute delay) ? |
| ACW (ASX) Chart |